palmitoylethanolamide.com.au
HomeResearchGraziano 2023

Role of PPAR-Allopregnanolone Signaling in Behavioral and Inflammatory Gut-Brain Axis Communications

Graziano Pinna. Biol Psychiatry. 2023 Oct 15;94(8):609-618.

ReviewHumansOther animals

Design
Review
Subjects
Not applicable; a narrative review
Dose used in the study
Not stated in the abstract
Duration
Not stated in the abstract
What was measured
How PPAR-alpha and the neurosteroid allopregnanolone link the gut microbiome, inflammation and mood

What the authors reported

Stress and obesogenic diets are proposed to suppress PPAR-alpha in brain, gut, fat and immune cells, favouring inflammation and mood instability, while PPAR-alpha modulators, including palmitoylethanolamide, are said to improve microbiome composition, inflammation and anxiety or depression in rodent models. PPAR-alpha and allopregnanolone in the colon are put forward as mediators of gut-brain communication.

Limits of this study

A narrative review and hypothesis paper, not new data. Much of the cited evidence is from rodent models. Funding and conflicts not stated in the abstract.

Source

PubMed 37156350 · doi:10.1016/j.biopsych.2023.04.025

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.